World Health Organisation said it will set up a Global Centre for Traditional Medicine in India, with PM Mod expressing confidence that just like the country has emerged as the 'pharmacy of the world'
Natco Pharma said its marketing partner Breckenridge Pharmaceutical received final approval from the USFDA for Pomalidomide Capsules, treatment of patients suffering from multiple myeloma cancer
Moderna said it has enough data for a first interim analysis of the late-stage trial of its experimental Covid-19 vaccine, which should help determine the vaccine's efficacy
The scheme is in addition to the already announced Rs 51,311 crore PLI for three sectors which takes the total around Rs 2 trn
Important scientific announcements are usually made through peer-reviewed medical research papers, not company press releases
The FDA authorised the experimental treatment, called bamlanivimab, for use against mild-to-moderate Covid-19 in adults, including those who are 65 and older, and pediatric patients
The formulation is the active biological component of black cumin; it fortifies the immunity and ensures higher success in fighting infection, the company says
Drug firm Lupin said the US health regulator has issued 13 observations after inspection of its subsidiary's Somerset facility in New Jersey
Drug firm Alembic Pharmaceuticals said it has received tentative approval from the US health regulator for Palbociclib capsules, used to treat a certain type of breast cancer
Europe, not India, will be the 1st target if US reduces import dependence: Experts
The company's prescription biz grew 14% YoY supported by continued traction in the Covid portfolio
Fosun-owned Gland Pharma sets price band for its IPO at Rs 1,490-1,500 per share
Barring Cipla and Glenmark, whose sales have grown in double digits due to demand for their Covid-19 drugs like favipiravir, tocilizumab, most big players have posted tepid growth
Private equity fund PAG is picking up a controlling stake in active pharmaceutical ingredient (API) maker Anjan Drug for over USD 70 million, sources said on Monday
Industry says fresh prescriptions are picking up
The reputation and relationships have helped pharma industry raise huge amounts of PE capital in 2020.
The company's product is a therapeutic equivalent generic version of Biogen's Tecfidera delayed-release capsules, the Hyderabad-based drug firm said in a statement
The global demand scenario for Indian pharmaceutical industry is largely expected to remain stable due to inelastic nature of prescription drugs, investment information agency ICRA has said.
Exports and domestic formulations account for an almost equal share in the Rs 2.8-trillion domestic pharma sector, CRISIL said
It had posted a sales turnover of Rs 75.48 crore in the corresponding first quarter of previous fiscal year, a statement by the ministry said